Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Disintegration of New Aspirin Disintegrating Tablets vs Ibuprofen
NCT03225352Phase 1Completed
- Sponsor
- Bayer
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin in pain (4 arms), sponsored by Bayer. Primary endpoint: Time to complete tablet disintegration up to 4 hours. Started Aug 2017; status: completed.
02
Drugs
aspirin
03
Conditions
pain
Beyond the preview
Go deeper on NCT03225352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225352.